Computationally optimized broadly reactive antigens for H5N1 and H1N1 influenza viruses
A technology for influenza and influenza hemagglutinin, applied in the direction of viral antigen components, antisense single-stranded RNA viruses, viruses, etc., can solve problems such as increasing the risk of infection
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0114] Example 1: Generation of H5N1 Influenza COBRA Sequences
[0115] This example describes the use of 426 human H5N1 influenza HA sequences from clades 0, 1, 2.1, 2.2, 2.3 and 7 to generate the H5N1 influenza HA COBRA consensus sequence. The resulting COBRA sequence was referred to as "PATH H5N1 COBRA".
[0116] To generate the final H5N1 influenza HA COBRA sequence, three levels of consensus sequences were generated ( figure 1 ). In the first tier, (1) 5 isolates from clade 0; (2) 86 isolates from clade 1; (3) 106 isolates from clade 2.1; (4) 97 isolates from clade 2.2 isolates; (5) 34 clade 2.3 isolates and (6) 1 clade 7 isolate, resulting in 6 independent consensus sequences. In the second level, a clade 2 consensus sequence was generated using the 3 clade 2 consensus sequences generated in the first level (clade 2.1, clade 2.2 and clade 2.3 consensus sequences). Using the individual clade 0, clade 1 and clade 7 consensus sequences generated in the first level and t...
Embodiment 2
[0119] Example 2: Generation of H1N1 Influenza COBRA Sequences
[0120] This example describes the use of 205 human and porcine H1N1 influenza HA sequences to generate the H1N1 influenza HA COBRA consensus sequence. The resulting COBRA sequence is referred to as "PATH H1N1 COBRA".
[0121] To generate the final H1N1 influenza HA COBRA sequence, two levels of consensus sequences were generated ( figure 2 ). In the first tier, (1) 8 human strains isolated in 1933-1934; (2) 13 human strains isolated in 1935-1947; (3) 12 human strains isolated in 1948-1957 were used; ( 4) 123 human strains and (5) 49 porcine strains isolated from 2009-2011, resulting in 5 independent consensus sequences. Using the 5 independent consensus sequences generated in the first tier, a final consensus sequence was generated. The PATH H1N1 COBRA sequence is shown below and presented herein as SEQ ID NO:2.
[0122] PATH H1N1 COBRA HA (SEQ ID NO: 2)
[0123] MKARLLVLLCALAATDADTICIGYHANNSTDTVDTVLEKNVTV...
Embodiment 3
[0124] Example 3: Codon-optimized COBRA gene sequence
[0125] The COBRA amino acid sequence disclosed herein was back translated and optimized for expression in mammalian cells, including codon usage and RNA optimization (GeneArt; Regensburg, Germany). The optimized nucleic acid sequence can be inserted into an appropriate expression vector, such as the pTR600 expression vector (US Patent Application Publication No. 2002 / 0106798; Ross et al., Nat Immunol. 1(2): 102-103, 2000; Green et al. , Vaccine 20:242-248, 2001). Expression vectors encoding the codon-optimized COBRA gene sequence can be used, for example, to produce VLPs containing the COBRA HA.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


